Csenge Advisory Group purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 14,011 shares of the company’s stock, valued at approximately $1,800,000.
Several other institutional investors also recently bought and sold shares of MKGAF. AssuredPartners Investment Advisors LLC purchased a new stake in Merck KGaA during the 2nd quarter worth approximately $1,056,000. Shepherd Financial Partners LLC acquired a new stake in shares of Merck KGaA in the second quarter worth approximately $4,202,000. Johnson Financial Group Inc. acquired a new stake in shares of Merck KGaA in the second quarter worth approximately $2,767,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Merck KGaA during the second quarter worth approximately $57,546,000. Finally, Kelman Lazarov Inc. purchased a new stake in shares of Merck KGaA during the second quarter worth approximately $448,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $167.38 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a 50-day simple moving average of $162.50 and a 200-day simple moving average of $148.28. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The stock has a market capitalization of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
